Page last updated: 2024-11-02

pioglitazone and Retinal Diseases

pioglitazone has been researched along with Retinal Diseases in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Retinal Diseases: Diseases involving the RETINA.

Research Excerpts

ExcerptRelevanceReference
"Pioglitazone pretreatment also suppressed NF-κB activation and altered GFAP overexpression."5.39Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats. ( Xiao, YQ; Ye, W; Zhang, XY; Zhang, Y, 2013)
"Pioglitazone pretreatment also suppressed NF-κB activation and altered GFAP overexpression."1.39Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats. ( Xiao, YQ; Ye, W; Zhang, XY; Zhang, Y, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, XY1
Xiao, YQ1
Zhang, Y1
Ye, W1

Other Studies

1 other study available for pioglitazone and Retinal Diseases

ArticleYear
Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats.
    Investigative ophthalmology & visual science, 2013, Jun-06, Volume: 54, Issue:6

    Topics: Animals; bcl-2-Associated X Protein; Blotting, Western; Cell Count; Cell Survival; Disease Models, A

2013